Phototherapy units are medical devices that deliver specific wavelengths of light to treat various clinical conditions — most commonly neonatal jaundice (hyperbilirubinemia) and dermatological disorders like psoriasis, vitiligo, and eczema. In neonatal care, phototherapy is the first-line treatment for jaundice, using blue-spectrum light to break down excess bilirubin in a newborn's skin. In dermatology, ultraviolet phototherapy provides targeted UV exposure to treat chronic skin conditions.
Whether you're outfitting a newborn nursery or NICU, adding dermatological phototherapy to your practice, or upgrading to LED-based systems, BuyOnMedix connects healthcare facilities with trusted suppliers offering new, certified refurbished, and lease-to-own phototherapy systems at competitive prices.
Phototherapy is a proven, essential treatment modality in both neonatal and dermatological care:
Phototherapy systems are designed for specific clinical applications with optimized light sources and delivery methods.
Devices positioned above the infant's bassinet or warmer that deliver blue-spectrum light (420–490 nm) to the baby's skin. Modern LED-based overhead units provide high-intensity, focused light with minimal heat generation. Popular models include the GE Lullaby, Natus neoBLUE, and Draeger BiliLux.
Pads or blankets containing fiber-optic light sources that wrap around or lay beneath the infant, delivering phototherapy through direct skin contact. They allow parents to hold and feed the baby during treatment, improving bonding and compliance. The Natus Biliblanket is the best-known fiber-optic system.
Units that combine overhead and underneath (fiber-optic) phototherapy for intensive treatment of severe jaundice, maximizing the skin surface area exposed to therapeutic light.
Dermatological systems emitting narrowband UVB light (311–312 nm), the most effective and widely used form of UV phototherapy for psoriasis, vitiligo, eczema, and other skin conditions. Available as full-body panels, targeted handheld devices, and enclosed treatment booths.
Systems delivering UVA light (320–400 nm) used in combination with psoralen medication (PUVA therapy) for severe psoriasis and cutaneous T-cell lymphoma. Less commonly used than narrowband UVB but still important for specific indications.
Selecting a phototherapy system depends on your clinical application, patient population, and treatment volume:
Phototherapy pricing varies based on type, technology, and clinical application:
Neonatal phototherapy typically runs continuously for 24–72 hours depending on bilirubin levels and response. Mild jaundice may resolve in 24 hours. Severe cases may require 48–72+ hours of continuous intensive phototherapy. Bilirubin levels are monitored every 4‒12 hours to assess response.
LED phototherapy delivers more focused, higher-intensity blue light with minimal heat and very long lamp life (20,000–50,000 hours). Fluorescent systems use special blue tubes that generate more heat and require frequent replacement (every 1,000–2,000 hours). LED is the preferred technology for new purchases.
LED lamps last 20,000–50,000+ hours and rarely need replacement during the unit's lifespan. Fluorescent tubes need replacement every 1,000–2,000 hours of use, as their irradiance output degrades over time even if they still illuminate.
Yes. Phototherapy is considered very safe when used properly. The primary precaution is protecting the infant's eyes with appropriate phototherapy eye shields. Minor side effects may include loose stools, mild rash, and temperature instability, all of which are manageable and temporary.
A typical narrowband UVB treatment course for psoriasis involves 2–3 sessions per week for 15–30 sessions (approximately 2–3 months). Maintenance sessions may continue at reduced frequency. Treatment protocols are individualized based on condition severity and response.
Ready to source from verified, certified suppliers worldwide?
Browse on MedIX